References
- Idris AM, Ibrahim SO, Vasstrand EN, et al. The Swedish snus and the Sudanese toombak: are they different?. Oral Oncol. 1998;34:558–566.
- Overland S, Skogen JC, Lissner L, et al. Snus use and cardiovascular risk factors in the general population: the HUNT3 study. Addiction (Abingdon, England). 2013;108:2019–2028.
- Piano MR, Benowitz NL, Fitzgerald GA, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122:1520–1544.
- Biener L, McCausland K, Curry L, et al. Prevalence of trial of snus products among adult smokers. Am J Public Health. 2011;101:1874–1876.
- Norberg M, Malmberg G, Ng N, et al. Who is using snus? – time trends, socioeconomic and geographic characteristics of snus users in the ageing Swedish population. BMC Public Health. 2011;11:929.
- Benowitz NL, Porchet H, Sheiner L, et al. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Therapeut. 1988;44:23–28.
- Digard H, Errington G, Richter A, et al. Patterns and behaviors of snus consumption in Sweden. Nicotine Tob Res.2009;11:1175–1181.
- Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Int Med. 1992;232:327–334.
- Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10:1773–1782.
- Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.
- Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920.
- El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–880.
- Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335:205–208.
- Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population–the Kalixanda study. Alimentary Pharmacol Therapeutics 2006;23:1725–1733.
- Wahlqvist P, Reilly MC, Barkun A. Systematic review: the impact of gastro-oesophageal reflux disease on work productivity. Aliment Pharmacol Therapeut. 200615;24:259–272.
- Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831.
- Hallan A, Bomme M, Hveem K, et al. Risk factors on the development of new-onset gastroesophageal reflux symptoms. A population-based prospective Cohort study: the HUNT study. Am J Gastroenterol. 2015;110:393–400.
- Kadakia SC, Kikendall JW, Maydonovitch C, et al. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol. 1995;90:1785–1790.
- Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016;14:175–182.
- Nilsson M, Johnsen R, Ye W, et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut. 2004;53:1730–1735.
- Aro P, Ronkainen J, Storskrubb T, et al. Use of tobacco products and gastrointestinal morbidity: an endoscopic population-based study (the Kalixanda study). Eur J Epidemiol. 2010;25:741–750.
- Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42:968–977.
- Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66–72.
- Ness-Jensen E, Lindam A, Lagergren J, et al. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61:1390–1397.
- Langhammer A, Krokstad S, Romundstad P, et al. The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Med Res Methodol. 2012;12:143.
- Winding TN, Andersen JH, Labriola M, et al. Initial nonparticipation and loss to follow-up in a Danish youth cohort: implications for relative risk estimates. J Epidemiol Commun Health. 2014;68:137–144.
- Statistical Yearbook of Norway. Oslo: Statistics Norway; 2014.
- Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.
- Post A, Gilljam H, Rosendahl I, et al. Validity of self reports in a cohort of Swedish adolescent smokers and smokeless tobacco (snus) users. Tob Control. 2005;14:114–117.
- Adams AS, Soumerai SB, Lomas J, et al. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care. 1999;11:187–192.
- Hellqvist L, Rolandsson M, Hugoson A, et al. Dental caries and associated factors in a group of Swedish snus users. Swed Dent J. 2015;39:47–54.
- Rutqvist LE, Curvall M, Hassler T, et al. Swedish snus and the GothiaTek® standard. Harm Reduct J. 2011;8:11.